Fonar ROE 2010-2025 | FONR

Current and historical return on equity (ROE) values for Fonar (FONR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Fonar ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.01B $0.16B 5.04%
2024-12-31 $0.01B $0.16B 5.06%
2024-09-30 $0.01B $0.16B 6.36%
2024-06-30 $0.01B $0.16B 7.05%
2024-03-31 $0.01B $0.16B 7.12%
2023-12-31 $0.01B $0.16B 8.50%
2023-09-30 $0.01B $0.15B 7.28%
2023-06-30 $0.01B $0.15B 6.03%
2023-03-31 $0.01B $0.15B 6.76%
2022-12-31 $0.01B $0.15B 5.47%
2022-09-30 $0.01B $0.15B 6.91%
2022-06-30 $0.01B $0.15B 8.41%
2022-03-31 $0.01B $0.14B 7.86%
2021-12-31 $0.01B $0.14B 9.44%
2021-09-30 $0.01B $0.14B 8.87%
2021-06-30 $0.01B $0.14B 7.55%
2021-03-31 $0.01B $0.14B 7.68%
2020-12-31 $0.01B $0.13B 5.47%
2020-09-30 $0.01B $0.13B 5.54%
2020-06-30 $0.01B $0.13B 6.40%
2020-03-31 $0.01B $0.13B 8.94%
2019-12-31 $0.01B $0.13B 11.67%
2019-09-30 $0.01B $0.12B 12.04%
2019-06-30 $0.01B $0.12B 12.47%
2019-03-31 $0.02B $0.11B 17.55%
2018-12-31 $0.02B $0.11B 17.48%
2018-09-30 $0.02B $0.11B 19.39%
2018-06-30 $0.02B $0.10B 20.49%
2018-03-31 $0.02B $0.09B 18.18%
2017-12-31 $0.02B $0.09B 22.75%
2017-09-30 $0.02B $0.09B 24.28%
2017-06-30 $0.02B $0.08B 25.94%
2017-03-31 $0.02B $0.08B 28.04%
2016-12-31 $0.02B $0.07B 25.20%
2016-09-30 $0.02B $0.07B 24.90%
2016-06-30 $0.02B $0.06B 26.32%
2016-03-31 $0.01B $0.06B 25.69%
2015-12-31 $0.01B $0.06B 25.12%
2015-09-30 $0.01B $0.05B 23.88%
2015-06-30 $0.01B $0.05B 22.45%
2015-03-31 $0.01B $0.05B 20.94%
2014-12-31 $0.01B $0.05B 21.39%
2014-09-30 $0.01B $0.05B 22.35%
2014-06-30 $0.01B $0.05B 23.39%
2014-03-31 $0.01B $0.04B 24.54%
2013-12-31 $0.01B $0.04B 23.23%
2013-09-30 $0.01B $0.04B 25.20%
2013-06-30 $0.01B $0.04B 28.00%
2013-03-31 $0.00B $0.04B 21.92%
2012-12-31 $0.00B $0.01B 32.65%
2012-09-30 $0.00B $0.01B 36.36%
2012-06-30 $0.00B $0.01B 42.11%
2012-03-31 $0.00B $0.01B 36.36%
2011-12-31 $0.00B $0.01B 57.14%
2011-09-30 $0.00B $0.01B 150.00%
2011-06-30 $0.00B $0.01B -200.00%
2011-03-31 $0.00B $0.00B -50.00%
2010-12-31 $0.00B $0.00B -19.05%
2010-09-30 $0.00B $-0.01B 17.39%
2010-06-30 $0.00B $-0.01B 52.17%
2010-03-31 $0.00B $-0.01B 60.00%
2009-12-31 $0.00B $-0.01B 47.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.088B $0.103B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.811B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00